Validation of quantitative analysis of multiparametric prostate MR images for prostate cancer detection and aggressiveness assessment: A cross-imager study

Radiology

Volumn 271, Issue 2, 2014, Pages 461-471

  Peng, Yahui ^b   Jiang, Yulei ^a   Antic, Tatjana ^a   Giger, Maryellen L ^a   Eggener, Scott E ^a   Oto, Aytekin ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b BEIJING JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GADODIAMIDE; GLUCAGON; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC IMAGING EQUIPMENT; DISCRIMINANT ANALYSIS; ENDORECTAL COIL; GLEASON SCORE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMAGE PROCESSING; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PATIENT CARE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE CANCER; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; VALIDATION PROCESS;

ADULT; AGED; CONTRAST MEDIA; GADOLINIUM DTPA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84899500349     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.14131320     Document Type: Article

References (28)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62(1):10-29.
2. Hoeks CM, Barentsz JO, Hambrock T, et al. Prostate cancer: multiparametric MR imaging for detection, localization, and staging. Radiology 2011;261(1):46-66.
3. Moyer VA; U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012;157(2):120-134.
4. Kozlowski P, Chang SD, Jones EC, Berean KW, Chen H, Goldenberg SL. Combined diffusion-weighted and dynamic contrastenhanced MRI for prostate cancer diagnosis-correlation with biopsy and histopathology. J Magn Reson Imaging 2006;24(1): 108-113.
5. Tanimoto A, Nakashima J, Kohno H, Shinmoto H, Kuribayashi S. Prostate cancer screening: the clinical value of diffusionweighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging 2007;25(1):146-152.
6. Vos PC, Barentsz JO, Karssemeijer N, Huisman HJ. Automatic computer-aided detection of prostate cancer based on multiparametric magnetic resonance image analysis. Phys Med Biol 2012;57(6):1527-1542.
7. Puech P, Betrouni N, Makni N, Dewalle AS, Villers A, Lemaitre L. Computer-assisted diagnosis of prostate cancer using DCE-MRI data: design, implementation and preliminary results. Int J CARS 2009;4(1):1-10.
8. Niaf E, Rouvière O, Mège-Lechevallier F, Bratan F, Lartizien C. Computer-aided diagnosis of prostate cancer in the peripheral zone using multiparametric MRI. Phys Med Biol 2012;57(12):3833-3851.
9. Peng Y, Jiang Y, Yang C, et al. Quantitative analysis of multiparametric prostate MR images: differentiation between prostate cancer and normal tissue and correlation with Gleason score- A computer-aided diagnosis development study. Radiology 2013;267(3):787-796.
10. Tretiakova M, Antic T, Binder D, et al. Microvessel density is not increased in prostate cancer: digital imaging of routine sections and tissue microarrays. Hum Pathol 2013;44(4):495-502.
11. Oto A, Kayhan A, Jiang Y, et al. Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. Radiology 2010;257(3):715-723.
12. Langer DL, van der Kwast TH, Evans AJ, et al. Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2-sparse versus dense cancers. Radiology 2008;249(3):900-908.
13. Chenevert TL, Galbán CJ, Ivancevic MK, et al. Diffusion coefficient measurement using a temperature-controlled fluid for quality control in multicenter studies. J Magn Reson Imaging 2011;34(4):983-987.
14. Metz CE. ROC methodology in radiologic imaging. Invest Radiol 1986;21(9):720-733.
15. Metz CE, Pan X. "Proper" binormal ROC curves: Theory and maximum-likelihood estimation. J Math Psychol 1999;43(1):1-33.
16. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143(1):29-36.
17. Fukunaga K. Introduction to statistical pattern recognition. 2nd ed. Boston, Mass: Academic Press, 1990; 131-136.
18. Fukunaga K. Introduction to statistical pattern recognition. 2nd ed. Boston, Mass: Academic Press, 1990; 219-224.
19. Riffenburgh RH. Statistics in medicine. 2nd ed. Amsterdam, the Netherlands: Elsevier Academic Press, 2006; 454-456.
20. Metz CE. ROC software. http://metz-roc.uchicago.edu. Accessed June 25, 2012.
21. Thörmer G, Otto J, Reiss-Zimmermann M, et al. Diagnostic value of ADC in patients with prostate cancer: influence of the choice of b values. Eur Radiol 2012;22(8):1820-1828.
22. Peng Y, Jiang Y, Antic T, et al. Apparent diffusion coefficient (ADC) for prostate cancer imaging: the impact of the b-values. AJR Am J Roentgenol (in press).
23. Tamada T, Sone T, Jo Y, et al. Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade. J Magn Reson Imaging 2008;28(3):720-726.
24. Woodfield CA, Tung GA, Grand DJ, Pezzullo JA, Machan JT, Renzulli JF 2nd. Diffusionweighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy. AJR Am J Roentgenol 2010;194(4):W316- W322.
25. Turkbey B, Shah VP, Pang Y, et al. Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? Radiology 2011;258(2):488-495.
26. Verma S, Rajesh A, Morales H, et al. Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy. AJR Am J Roentgenol 2011;196(2):374-381.
27. Itou Y, Nakanishi K, Narumi Y, Nishizawa Y, Tsukuma H. Clinical utility of apparent diffusion coefficient (ADC) values in patients with prostate cancer: can ADC values contribute to assess the aggressiveness of prostate cancer? J Magn Reson Imaging 2011;33(1):167-172.
28. Epstein JI, Netto GJ. Biopsy interpretation of the prostate. 4th ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2007; 175-202.